ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $626K of Zentalis Pharmaceuticals, Inc.
Sold$626,376
$62.64Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Wed, Jan 19 close, $60.04
- −21.3%
- S&P 500, same days
- −3.6%
Measured over 30 trading days, to the Mar 3 close.
Traded Tue, Jan 18. Filed Wed, Jan 19, 2:21 PM ET, during the session. Returns use the Jan 19 close and the Mar 3 close. Not investment advice.